NON-SMALL CELL LUNG CARCINOMA
Clinical trials for NON-SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets Tough-to-Treat lung cancer mutation
Disease control Not yet recruitingThis study is testing a new oral medication called BPI-361175 for adults with advanced non-small cell lung cancer (NSCLC) that has a specific genetic change called an EGFR mutation, including a hard-to-treat type known as C797S. The main goals are to find a safe and effective dos…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Xcovery Holdings, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Breathing in cancer drugs: new trial aims to boost lung cancer surgery success
Disease control Not yet recruitingThis study is testing if adding an inhaled drug called azacytidine to standard pre-surgery treatment can better shrink early-stage lung cancer tumors. The goal is to find the safest dose of the inhaled drug and see if it helps eliminate more cancer cells before surgery. About 60 …
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC